The burden of autoimmunity in myelodysplastic syndromes
C Fozza - Hematological oncology, 2018 - Wiley Online Library
The clinical history of patients with myelodysplastic syndromes (MDS) is characterised by
bone marrow insufficiency as well as by the possible evolution into acute leukaemia …
bone marrow insufficiency as well as by the possible evolution into acute leukaemia …
Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil
JT Lin, WS Wang, CC Yen, TJ Chiou, JH Liu… - Annals of …, 2002 - Springer
Autoimmune hemolytic anemia (AIHA) rarely occurs in myelodysplastic syndrome (MDS). A
36-year-old Asian female was diagnosed with MDS (refractory cytopenia with multilineage …
36-year-old Asian female was diagnosed with MDS (refractory cytopenia with multilineage …
[PDF][PDF] Autoimmune hemolytic anemia with Myelodysplastic syndrome
E Chalhoub, C Chalouhy, R Jambeih… - Kansas Journal of …, 2013 - journals.ku.edu
The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal cell disorders
characterized by ineffective hematopoiesis manifested by one or more cytopenias. 1 The …
characterized by ineffective hematopoiesis manifested by one or more cytopenias. 1 The …